These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 35462485)

  • 1. [Applied research of ultrasound attenuation parameter in the diagnosis of metabolic dysfunction-associated fatty liver disease].
    Hou MM; Yuan XW; Wang YQ; Zhang Y; Zhang SY; Yu SH; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):290-296. PubMed ID: 35462485
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population.
    Hu R; Wu B; Wang C; Wu Z; Zhang X; Chen X; Lu G; Yuan K
    Int J Surg; 2024 Apr; 110(4):2044-2054. PubMed ID: 38215263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease.
    Zhu SH; Zheng KI; Hu DS; Gao F; Rios RS; Li G; Li YY; Byrne CD; Targher G; Chen YP; Zheng MH
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):430-435. PubMed ID: 32398489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the clinical value of ultrasound attenuation parameters in evaluating liver steatosis degree in patients with chronic liver disease].
    Qiao J; Zhao W; Du JH; Zhang SY; Wang RQ; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):876-881. PubMed ID: 33105934
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Qu Y; Song YY; Chen CW; Fu QC; Shi JP; Xu Y; Xie Q; Yang YF; Zhou YJ; Li LP; Xu MY; Cai XB; Zhang QD; Yu H; Fan JG; Lu LG
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00323. PubMed ID: 33848277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients.
    Wang M; Tang S; Li G; Huang Z; Mo S; Yang K; Chen J; Du B; Xu J; Ding Z; Dong F
    BMC Gastroenterol; 2024 Feb; 24(1):81. PubMed ID: 38395765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of alanine aminotransferase levels and a histological diagnosis of steatohepatitis with ultrasound-diagnosed metabolic-associated fatty liver disease in patients from a centre in Nigeria.
    Kolawole OJ; Oje MM; Betiku OA; Ijarotimi O; Adekanle O; Ndububa DA
    BMC Gastroenterol; 2024 May; 24(1):147. PubMed ID: 38724942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard.
    Mu R; Xia YC; Zhu KY; Lu JY; Luo Q; Zhang L; Lin RK; Cai XB; Qu Y; Lu LG
    J Dig Dis; 2023 Dec; 24(12):691-701. PubMed ID: 37994615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement.
    Huang Z; Ng K; Chen H; Deng W; Li Y
    Front Endocrinol (Lausanne); 2021; 12():739875. PubMed ID: 35173677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method.
    Bende F; Sporea I; Șirli R; Bâldea V; Lazăr A; Lupușoru R; Fofiu R; Popescu A
    Med Ultrason; 2021 Feb; 23(1):7-14. PubMed ID: 33220028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of multiparameteric quantitative ultrasound for assessing high-risk steatohepatitis].
    Li XX; Cheng GW; Qiao XH; Xue LY; Huang C; Huang XJ; Yao QY; Ding H
    Zhonghua Gan Zang Bing Za Zhi; 2024 Sep; 32(9):820-827. PubMed ID: 39375103
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic steatosis leads to overestimation of liver stiffness measurement in both chronic hepatitis B and metabolic-associated fatty liver disease patients.
    Liu J; Ma Y; Han P; Wang J; Liu YG; Shi RF; Li J
    Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101957. PubMed ID: 35609821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort.
    Dioguardi Burgio M; Ronot M; Reizine E; Rautou PE; Castera L; Paradis V; Garteiser P; Van Beers B; Vilgrain V
    Eur Radiol; 2020 Apr; 30(4):2293-2301. PubMed ID: 31822978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of ultrasound attenuation imaging and shear wave elastography in the diagnosis of metabolic fatty liver disease.
    Ma Q; Gong L; Ma L; Jiang T
    Biotechnol Genet Eng Rev; 2024 Nov; 40(3):2830-2841. PubMed ID: 37078413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound attenuation imaging: a reproducible alternative for the noninvasive quantitative assessment of hepatic steatosis in children.
    Dardanelli EP; Orozco ME; Oliva V; Lutereau JF; Ferrari FA; Bravo MG; Ruvinsky S; Roel M; Barvosa PC; Armeno M; Kaplan JS
    Pediatr Radiol; 2023 Jul; 53(8):1618-1628. PubMed ID: 36869263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of FibroTouch in assessing liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease combined with type 2 diabetes mellitus.
    Yu H; Liu H; Zhang J; Jia G; Yang L; Zhang Q; Li G; Liu F; Di F; Wang F
    Ann Palliat Med; 2021 Sep; 10(9):9702-9714. PubMed ID: 34628896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Fat Quantification by Ultrasound in Children: A Prospective Study.
    D'Hondt A; Rubesova E; Xie H; Shamdasani V; Barth RA
    AJR Am J Roentgenol; 2021 Oct; 217(4):996-1006. PubMed ID: 33438457
    [No Abstract]   [Full Text] [Related]  

  • 19. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
    Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
    Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study.
    Yoo JJ; Yoo YJ; Moon WR; Kim SU; Jeong SW; Park HN; Park MG; Jang JY; Park SY; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kim SG; Kim YS; Kim JH; Yeon JE; Byun KS
    Korean J Intern Med; 2020 Nov; 35(6):1346-1353. PubMed ID: 31694366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.